Depression and anxiety in women are frequently attributed to psychological stressors, life circumstances, or neurochemical imbalances requiring antidepressant medication. What is less commonly discussed — and what leads to years of undertreated suffering for many women — is that estrogen and progesterone decline is a direct neurological driver of mood disorders. When hormone deficiency is the root cause, HRT often achieves what antidepressants cannot.
How Hormones Affect Mood
Estrogen, progesterone, and testosterone are not exclusively reproductive hormones — they are potent neuroactive molecules with direct effects on the brain:
Want to talk it through with our team?
Book a free 15-minute video consult. Start for $247 — includes your first doctor visit. No membership.
- Estrogen regulates serotonin receptor density, dopamine signaling, and BDNF (brain-derived neurotrophic factor — a key driver of neuroplasticity and mood regulation). Estrogen decline reduces serotonin availability in ways that can mimic major depressive disorder
- Progesterone converts to allopregnanolone, a potent GABA-A receptor modulator that produces anxiolytic (anti-anxiety) and sedative effects. Progesterone deficiency — which often begins in perimenopause before estrogen declines significantly — directly increases anxiety and reduces sleep quality
- Testosterone in women contributes to mood, energy, and motivation; low testosterone produces a distinct pattern of low-grade depression and apathy that often does not respond to SSRIs
The Evidence for HRT in Mood Disorders
The research on HRT for depression and anxiety in perimenopausal and menopausal women is substantial:
- Multiple randomized controlled trials demonstrate that transdermal estradiol is significantly more effective than placebo for depressive symptoms in perimenopausal women — with effect sizes comparable to antidepressants
- The Helping Older Women with Resistance and Endurance (POWER) trial and others show that early initiation of HRT (within 10 years of menopause) produces measurable mood benefits beyond symptom relief
- Oral micronized progesterone (bioidentical) demonstrates anxiolytic effects through its GABA-A activity — effects not seen with synthetic progestins (medroxyprogesterone acetate), which may actually worsen mood in some women
- The North American Menopause Society (NAMS) recognizes hormone therapy as first-line treatment for mood symptoms specifically attributable to menopause
When to Consider Hormones Instead of (or Before) Antidepressants
Women who present with depression or anxiety in the following contexts should have hormone evaluation before or alongside psychiatric medication:
- Onset of symptoms in the mid-to-late 40s, particularly coinciding with menstrual changes
- Mood symptoms accompanied by physical perimenopause symptoms (hot flashes, sleep disruption, joint pain)
- Poor or partial response to multiple antidepressant trials
- Premenstrual dysphoric disorder (PMDD) — hormonal progesterone fluctuation is the mechanism
- Postpartum depression — progesterone drops precipitously after delivery; for some women this is the trigger
- Return of depression after surgical menopause (bilateral oophorectomy)
Hormone-Specific Mood Patterns
| Hormone Deficiency | Characteristic Mood Pattern |
|---|---|
| Estrogen deficiency | Low mood, tearfulness, reduced pleasure, cognitive slowing — resembles classic MDD |
| Progesterone deficiency | Anxiety, irritability, sleep disruption (especially early AM waking), mood volatility — resembles anxiety disorder or PMDD |
| Testosterone deficiency (women) | Flat affect, apathy, low motivation, blunted drive — resembles treatment-resistant depression |
| Thyroid deficiency | Low mood, cognitive slowing, fatigue — nearly identical to depression; must be excluded in every case |
What HRT for Mood Looks Like
For perimenopausal and postmenopausal women with hormone-driven mood symptoms:
- Transdermal estradiol: First-line for mood symptoms alongside vasomotor symptoms; patch or gel; consistent serum levels without first-pass liver metabolism
- Oral micronized progesterone: Specifically for anxiety and sleep symptoms; nightly dosing leverages its sedating GABA-A effect
- Low-dose testosterone: Added when flat affect and low motivation persist despite estrogen/progesterone optimization
Mood improvement with HRT typically begins within 4–8 weeks of starting treatment at adequate doses. Some women require dose adjustments before full effect is achieved.
MultiGen Wellness evaluates the full hormone panel before making any recommendations. If hormones are driving mood symptoms, the right treatment is hormonal — not a cycle of antidepressants. Book your free 15-minute consult below to get started.
How it works
From your first call to medication at your door.
- AFree 15-minute video consult. We go over your goals, answer your questions, and confirm we can treat you in your state.
- BStart for $247, which includes your first doctor visit.
- CLab work: free with insurance at Quest or any other lab. Book your Quest visit in your patient portal, or take our lab order form to any lab that takes your insurance.
- DDoctor visit: once results are back, meet by video with a dedicated hormone therapy specialist (PAs, NPs and doctors on staff) to review labs and plan medication or therapy.
- EMedication shipped to your door. We bill you for the medication and ship it to your house. See medication prices
What it costs
- No monthly fee, no membership, no commitment.
- $97 per visit, only when needed.
- Prescriptions need lab work and a video visit at least every 90 days.
- Most new patients are seen every 30 days at first.